These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 15266928)

  • 1. Bacteriophage therapy: an alternative to conventional antibiotics.
    Mathur MD; Vidhani S; Mehndiratta PL
    J Assoc Physicians India; 2003 Jun; 51():593-6. PubMed ID: 15266928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics.
    Ahmad SI
    Med Hypotheses; 2002 Apr; 58(4):327-31. PubMed ID: 12027527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophage therapy in children: facts and prospects.
    Fortuna W; Miedzybrodzki R; Weber-Dabrowska B; Górski A
    Med Sci Monit; 2008 Aug; 14(8):RA126-32. PubMed ID: 18668009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophages show promise as antimicrobial agents.
    Alisky J; Iczkowski K; Rapoport A; Troitsky N
    J Infect; 1998 Jan; 36(1):5-15. PubMed ID: 9515662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophages as potential new therapeutics to replace or supplement antibiotics.
    Kutateladze M; Adamia R
    Trends Biotechnol; 2010 Dec; 28(12):591-5. PubMed ID: 20810181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New perspectives of the phage therapy].
    Eyer L; Pantůcek R; Růzicková V; Doskar J
    Klin Mikrobiol Infekc Lek; 2007 Dec; 13(6):231-5. PubMed ID: 18320502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage therapy: past history and future prospects.
    Carlton RM
    Arch Immunol Ther Exp (Warsz); 1999; 47(5):267-74. PubMed ID: 10604231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phagotherapy in terms of bacteriophage genetics: hopes, perspectives, safety, limitations].
    Krylov VN
    Genetika; 2001 Jul; 37(7):869-87. PubMed ID: 11558226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophages: an appraisal of their role in the treatment of bacterial infections.
    Hanlon GW
    Int J Antimicrob Agents; 2007 Aug; 30(2):118-28. PubMed ID: 17566713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacteriophages as antibacterial agents].
    Shasha SM; Sharon N; Inbar M
    Harefuah; 2004 Feb; 143(2):121-5, 166. PubMed ID: 15143702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophage therapy: a potential solution for the antibiotic resistance crisis.
    Golkar Z; Bagasra O; Pace DG
    J Infect Dev Ctries; 2014 Feb; 8(2):129-36. PubMed ID: 24518621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophage therapy: exploiting smaller fleas.
    Deresinski S
    Clin Infect Dis; 2009 Apr; 48(8):1096-101. PubMed ID: 19275495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.
    Burrowes B; Harper DR; Anderson J; McConville M; Enright MC
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):775-85. PubMed ID: 21905786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophage treatment as an alternative therapy for multidrug-resistant bacteria.
    Alqahtani A
    Saudi Med J; 2023 Dec; 44(12):1222-1231. PubMed ID: 38016738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophage therapy.
    Summers WC
    Annu Rev Microbiol; 2001; 55():437-51. PubMed ID: 11544363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy.
    Ryan EM; Gorman SP; Donnelly RF; Gilmore BF
    J Pharm Pharmacol; 2011 Oct; 63(10):1253-64. PubMed ID: 21899540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is phage therapy acceptable in the immunocompromised host?
    Borysowski J; Górski A
    Int J Infect Dis; 2008 Sep; 12(5):466-71. PubMed ID: 18400541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of experimental infections of mice with bacteriophages.
    Soothill JS
    J Med Microbiol; 1992 Oct; 37(4):258-61. PubMed ID: 1404324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.